慢性高血压孕妇发生子痫前期时胎盘形成受损程度较轻
本研究基于孕11+0至13+6周前瞻性筛查数据,比较慢性高血压(CH)合并子痫前期(PE)孕妇(n=283)与无CH的PE孕妇(n=2236)的胎盘形成标志物。两组均表现为平均动脉压(MAP)和子宫动脉搏动指数(UtA-PI)升高、胎盘生长因子(PlGF)和妊娠相关血浆蛋白-A(PAPP-A)降低,但CH组MAP MoM、PlGF MoM和PAPP-A MoM高于无CH组,UtA-PI MoM低于无CH组(均P<0.01)。结论认为CH孕妇发生PE时胎盘形成受损程度较轻。
要点
- CH合并PE孕妇的MAP MoM、PlGF MoM和PAPP-A MoM高于无CH的PE孕妇。
- CH合并PE孕妇的UtA-PI MoM低于无CH的PE孕妇。
- 两组胎盘形成标志物异常程度均随PE分娩孕周增加而减轻。
核心结论
- 发生PE的孕妇中,CH孕妇在孕11-13周反映胎盘形成受损的高UtA-PI和低PlGF、PAPP-A程度轻于无CH孕妇。
研究设计与样本
- 前瞻性筛查研究,纳入单胎妊娠孕妇,在孕11+0至13+6周首次常规医院就诊时记录母体特征和病史,测量MAP、UtA-PI、血清PlGF和PAPP-A,并转换为中位数倍数(MoM)。
- 比较CH合并PE孕妇(n=283)与无CH的PE孕妇(n=2236)的MoM值。
主要发现
- 两组CH和无CH的PE孕妇均表现为MAP和UtA-PI测量值升高、PlGF和PAPP-A降低,且所有标志物偏离正常的程度随PE分娩孕周增加而减轻。
- 两组间log10 MoM生物标志物对PE分娩孕周回归线的斜率无显著差异。
- 两组生物标志物的截距和系数存在显著差异:CH组MAP MoM、PlGF MoM和PAPP-A MoM高于无CH组,UtA-PI MoM低于无CH组(均P<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the degree of impaired placentation in women with and those without chronic hypertension (CH) who develop pre-eclampsia (PE) in pregnancy. METHODS: Data were derived from prospective screening for adverse pregnancy outcomes in women with singleton pregnancy attending their first routine hospital visit at 11 + 0 to 13 + 6 weeks' gestation. This visit included recording of maternal characteristics and medical history and measurement of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum placental growth factor (PlGF) and serum pregnancy-associated plasma protein-A (PAPP-A). The measured biomarkers were converted to multiples of the median (MoM) after adjustment for pregnancy characteristics. MoM values in women with CH who developed PE (n = 283) were compared to those of women without CH who developed PE (n = 2236). RESULTS: In both groups with and without CH, measurements of MAP and UtA-PI were increased, whereas those of PlGF and PAPP-A were decreased and the deviation from normal in all biomarkers decreased with advancing gestational age at delivery with PE. There was no significant difference between women with and those without CH in the slope of the regression line of log10 MoM biomarker values against gestational age at delivery with PE for any of the biomarkers. However, there was a significant difference in the intercepts and coefficients of biomarkers in the two groups; compared to those without CH, MAP MoM, PlGF MoM and PAPP-A MoM were higher and UtA-PI MoM was lower in the CH group (all P < 0.01). CONCLUSION: In pregnancies that develop PE, the degree of impaired placentation, reflected in high UtA-PI and low PlGF and PAPP-A at 11-13 weeks' gestation, is less in women with CH than in those without CH. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Panaitescu AM, Akolekar R, Kametas N, et al. Impaired placentation in women with chronic hypertension who develop pre-eclampsia. Ultrasound Obstet Gynecol. 2017. PMID: 28470791. doi:10.1002/uog.17517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。